Emerging therapies and their delivery for treating age‐related macular degeneration
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging therapies and their delivery for treating age‐related macular degeneration
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-03-26
DOI
10.1111/bph.15459
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles
- (2020) Hiroki Tsujinaka et al. Nature Communications
- Risuteganib—a novel integrin inhibitor for the treatment of non-exudative (dry) age-related macular degeneration and diabetic macular edema
- (2020) Lincoln T. Shaw et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Predicting conversion to wet age-related macular degeneration using deep learning
- (2020) Jason Yim et al. NATURE MEDICINE
- Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration
- (2020) Derek Kunimoto et al. OPHTHALMOLOGY
- The TSPO-NOX1 axis controls phagocyte-triggered pathological angiogenesis in the eye
- (2020) Anne Wolf et al. Nature Communications
- HAWK and HARRIER
- (2020) Pravin U. Dugel et al. OPHTHALMOLOGY
- Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration
- (2020) Arshad M. Khanani et al. JAMA Ophthalmology
- Treatment with interleukin‐33 is non‐toxic and protects retinal pigment epithelium in an ageing model of outer retinal degeneration
- (2020) Alison J. Clare et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration
- (2020) Glenn J. Jaffe et al. OPHTHALMOLOGY
- Mapping physical tumor microenvironment and drug delivery
- (2019) Hadi T. Nia et al. CLINICAL CANCER RESEARCH
- Clinical-grade stem cell–derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs
- (2019) Ruchi Sharma et al. Science Translational Medicine
- The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
- (2019) Peter A. Campochiaro et al. OPHTHALMOLOGY
- HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
- (2019) Pravin U. Dugel et al. OPHTHALMOLOGY
- A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration
- (2019) James T. Handa et al. Nature Communications
- Complement system and age-related macular degeneration: drugs and challenges
- (2019) Jiali Wu et al. Drug Design Development and Therapy
- Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration
- (2019) Leon von der Emde et al. Scientific Reports
- An in vitro Assessment of Thermo-Reversible Gel Formulation Containing Sunitinib Nanoparticles for Neovascular Age-Related Macular Degeneration
- (2019) Priyanka Bhatt et al. AAPS PHARMSCITECH
- Intravitreal Combined Aflibercept + Anti–Platelet-Derived Growth Factor Receptor β for nAMD: Results of the Phase 2 CAPELLA Trial
- (2019) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal Disease
- (2019) Yusaku Matsuda et al. Molecular Therapy-Nucleic Acids
- THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets
- (2019) Stephen P H Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease
- (2019) Mohd Nasir Mat Nor et al. Neurotherapeutics
- IL-33 deficiency causes persistent inflammation and severe neurodegeneration in retinal detachment
- (2019) Josy Augustine et al. Journal of Neuroinflammation
- Cell penetrating peptides in ocular drug delivery: State of the art
- (2018) S. Pescina et al. JOURNAL OF CONTROLLED RELEASE
- Phase 1 clinical study of an embryonic stem cell–derived retinal pigment epithelium patch in age-related macular degeneration
- (2018) Lyndon da Cruz et al. NATURE BIOTECHNOLOGY
- Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration
- (2018) Philip J. Rosenfeld et al. OPHTHALMOLOGY
- A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration
- (2018) Amir H. Kashani et al. Science Translational Medicine
- Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration
- (2018) Frank G. Holz et al. JAMA Ophthalmology
- Encapsulated Cell Technology-Based Delivery of a Complement Inhibitor Reduces Choroidal Neovascularization in a Mouse Model
- (2018) Balasubramaniam Annamalai et al. Translational Vision Science & Technology
- Modulation of three key innate immune pathways for the most common retinal degenerative diseases
- (2018) Isha Akhtar‐Schäfer et al. EMBO Molecular Medicine
- Lessons from Recent Phase III Trial Failures: Don't Design Phase III Trials Based on Retrospective Subgroup Analyses from Phase II Trials
- (2018) Philip J. Rosenfeld et al. OPHTHALMOLOGY
- Systemic immunosuppression and risk of age-related macular degeneration
- (2018) Harpal S. Sandhu et al. PLoS One
- The Developing Regorafenib Eye drops for neovascular Age-related Macular degeneration (DREAM) study: an open-label phase II trial
- (2018) Antonia M. Joussen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration
- (2018) David Callanan et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial
- (2017) Jeffrey S Heier et al. LANCET
- Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration
- (2017) Michiko Mandai et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration
- (2017) Glenn J. Jaffe et al. OPHTHALMOLOGY
- Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial
- (2017) Pravin U. Dugel et al. OPHTHALMOLOGY
- Pharmacokinetic aspects of retinal drug delivery
- (2017) Eva M. del Amo et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration
- (2017) Brian L. Yaspan et al. Science Translational Medicine
- An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications
- (2017) Evan N. Dunn et al. Ophthalmic Surgery Lasers & Imaging Retina
- iPSC-Derived Retina Transplants Improve Vision in rd1 End-Stage Retinal-Degeneration Mice
- (2017) Michiko Mandai et al. Stem Cell Reports
- Interferon‐beta signaling in retinal mononuclear phagocytes attenuates pathological neovascularization
- (2016) Anika Lückoff et al. EMBO Molecular Medicine
- IBI302, a promising candidate for AMD treatment, targeting both the VEGF and complement system with high binding affinity in vitro and effective targeting of the ocular tissue in healthy rhesus monkeys
- (2016) Xinyi Ren et al. EXPERIMENTAL EYE RESEARCH
- Subretinal implantation of a monolayer of human embryonic stem cell-derived retinal pigment epithelium: a feasibility and safety study in Yucatán minipigs
- (2016) Michael J. Koss et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- IL-33 amplifies an innate immune response in the degenerating retina
- (2016) Hongkang Xi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interleukin-33 regulates tissue remodelling and inhibits angiogenesis in the eye
- (2016) Sofia Theodoropoulou et al. JOURNAL OF PATHOLOGY
- A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration
- (2016) Glenn J. Jaffe et al. OPHTHALMOLOGY
- Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration
- (2016) Frank G. Holz et al. OPHTHALMOLOGY
- Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration
- (2016) Ian J. Constable et al. EBioMedicine
- HL-217, a new topical anti-angiogenic agent, inhibits retinal vascular leakage and pathogenic subretinal neovascularization in Vldlr−/− mice
- (2015) Junghyun Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting translocator protein (18 kDa) (TSPO) dampens pro-inflammatory microglia reactivity in the retina and protects from degeneration
- (2015) Rebecca Scholz et al. Journal of Neuroinflammation
- Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial
- (2015) Elizabeth P Rakoczy et al. LANCET
- RIKEN suspends first clinical trial involving induced pluripotent stem cells
- (2015) Ken Garber NATURE BIOTECHNOLOGY
- Clinical Evaluation of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections in Subjects with Neovascular Age-Related Macular Degeneration
- (2015) Karl G. Csaky et al. OPHTHALMOLOGY
- PHASE II, RANDOMIZED, PLACEBO-CONTROLLED, 90-DAY STUDY OF EMIXUSTAT HYDROCHLORIDE IN GEOGRAPHIC ATROPHY ASSOCIATED WITH DRY AGE-RELATED MACULAR DEGENERATION
- (2015) Pravin U. Dugel et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- GEOGRAPHIC ATROPHY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2015) Luna Xu et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Immune mechanisms in inflammatory and degenerative eye disease
- (2015) Victor L. Perez et al. TRENDS IN IMMUNOLOGY
- IL10-driven STAT3 signalling in senescent macrophages promotes pathological eye angiogenesis
- (2015) Rei Nakamura et al. Nature Communications
- Treatment of Exudative Age-Related Macular Degeneration with a Designed Ankyrin Repeat Protein that Binds Vascular Endothelial Growth Factor: a Phase I/II Study
- (2014) Eric H. Souied et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Interleukin-18 Has Antipermeablity and Antiangiogenic Activities in the Eye: Reciprocal Suppression With VEGF
- (2014) Jikui Shen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- IL-18 is not therapeutic for neovascular age-related macular degeneration
- (2014) Yoshio Hirano et al. NATURE MEDICINE
- IL-18 Attenuates Experimental Choroidal Neovascularization as a Potential Therapy for Wet Age-Related Macular Degeneration
- (2014) S. L. Doyle et al. Science Translational Medicine
- Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
- (2014) Wan Ling Wong et al. Lancet Global Health
- Characterization of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cell Sheets Aiming for Clinical Application
- (2014) Hiroyuki Kamao et al. Stem Cell Reports
- Pazopanib eye drops: a randomised trial in neovascular age-related macular degeneration
- (2013) Ronald Danis et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
- (2013) K Ghasemi Falavarjani et al. EYE
- Amyloid-β-induced matrix metalloproteinase-9 secretion is associated with retinal pigment epithelial barrier disruption
- (2013) LINING CAO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
- (2013) Soraya Rofagha et al. OPHTHALMOLOGY
- Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration
- (2013) Zohar Yehoshua et al. OPHTHALMOLOGY
- NLRP3 Inflammasome Blockade Inhibits VEGF-A-Induced Age-Related Macular Degeneration
- (2013) Alexander G. Marneros Cell Reports
- Immunomodulatory drugs: Oral and systemic adverse effects
- (2013) A. Bascones-Martinez et al. Medicina Oral Patologia Oral y Cirugia Bucal
- Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans
- (2012) Tim U. Krohne et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Treatment of Diabetic Macular Edema With a Designed Ankyrin Repeat Protein That Binds Vascular Endothelial Growth Factor: A Phase I/II Study
- (2012) Peter A. Campochiaro et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- The Vitreous Humor As a Barrier to Nanoparticle Distribution
- (2012) Jenifer Mains et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components
- (2012) Sarah L Doyle et al. NATURE MEDICINE
- Low-Dose Lipopolysaccharide Pretreatment Suppresses Choroidal Neovascularization via IL-10 Induction
- (2012) Nagakazu Matsumura et al. PLoS One
- Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats
- (2011) Yousef Yafai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A Non Membrane-Targeted Human Soluble CD59 Attenuates Choroidal Neovascularization in a Model of Age Related Macular Degeneration
- (2011) Siobhan M. Cashman et al. PLoS One
- Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration
- (2011) J.-D. Ding et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drug-Eluting Intraocular Lenses
- (2011) Clara González-Chomón et al. Materials
- A RANDOMIZED PILOT STUDY OF SYSTEMIC IMMUNOSUPPRESSION IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION WITH CHOROIDAL NEOVASCULARIZATION
- (2010) Robert B Nussenblatt et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Suppression and Regression of Choroidal Neovascularization by the Multitargeted Kinase Inhibitor Pazopanib
- (2009) Kyoichi Takahashi ARCHIVES OF OPHTHALMOLOGY
- IL-33 Raises Alarm
- (2009) Mohamed Lamkanfi et al. IMMUNITY
- A Dose-Escalation Study of Recombinant Human Interleukin-18 Using Two Different Schedules of Administration in Patients with Cancer
- (2008) M. J. Robertson et al. CLINICAL CANCER RESEARCH
- Targeting age-related macular degeneration with Alzheimer’s disease based immunotherapies: Anti-amyloid-β antibody attenuates pathologies in an age-related macular degeneration mouse model
- (2007) Jin-Dong Ding et al. VISION RESEARCH
- Cells Isolated from Umbilical Cord Tissue Rescue Photoreceptors and Visual Functions in a Rodent Model of Retinal Disease
- (2006) Raymond D. Lund et al. STEM CELLS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started